Frank Angst

Officials at LGC blamed delays on a spike in the number of samples that required follow-up testing after initial analysis.

The council will go along with several changes in withdrawal times and threshold levels that would move the state toward National Uniform Medication Program policies.

Officials at a Lexington, Kentucky, equine drug-testing laboratory blamed recent long delays in processing samples on a spike of nearly 100 times the number of usual suspicious results this year compared with 2013.

The 24-year-old stallion died Oct. 7 while recovering from surgery to treat neck-arthritis-related conditions.

Researchers recently found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage (EIPH) and long-term racing performance.

In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight of drug compounders.

While some prominent trainers called for phasing out use of race-day furosemide in a press release Aug. 1, top horsemen’s groups throughout the country said this week they have not changed their stance in supporting use of the diuretic.